An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer. - Chen Y; Lu X; Zhang L; Li Y; Chen H; Luo L; Pan Y; Gao B (Frontiers in immunology, 2026)